Literature DB >> 27328403

Triptolide Improves Diabetic Nephropathy by Regulating Th Cell Balance and Macrophage Infiltration in Rat Models of Diabetic Nephropathy.

H Guo1, C Pan1, B Chang1, X Wu1, J Guo1, Y Zhou1, H Liu1, Z Zhu1, B Chang1, L Chen1.   

Abstract

OBJECTIVE: To investigate the therapeutic effect of triptolide (TP) on diabetic nephropathy (DN) in addition to its influence on helper T lymphocytes (Th) cells and monocytes/macrophages in rat models of DN.
METHODS: Diabetes was induced in rats by feeding them high-fat diets and administering low-dose streptozotocin (STZ); subsequently, they were treated with TP (6, 12, or 24 mg/kg/day respectively) for 4 weeks. The general characteristics of the rats and their kidney weight to body weight ratio were observed. Liver and kidney function tests, routine blood tests, and 24 h urine protein tests were performed. Histological and ultrastructural pathologic changes in the kidneys were examined. Changes in the proportion of Th1/Th2 cells in peripheral blood and CD4(+) T cells were measured. The serum levels of interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-4, and IL-10 were determined and the expression of these 4 cytokines in the kidneys was measured. Expression of the CD68 macrophage surface marker as well as that of phospho-nuclear factor kappa B (p-NF-κB), NF-κB, monocyte chemoattractant protein (MCP)-1, transforming growth factor (TGF)-β1, fibronectin (FN), IL-12, and signal transducer and activator of transcription-4 (STAT4) was evaluated in the kidneys.
RESULTS: Elevated urine micro-albumin (UMA) and renal histological and ultrastructural changes were observed after the induction of diabetes. DN was associated with delayed immune-inflammatory responses induced by up-regulation of the proportion of Th1 cells and increase of the pro-inflammatory cytokines IFN-γ and TNF-α secreted by Th1 cells. In addition, down-regulation of the proportion of Th2 cells and decrease of the anti-inflammatory cytokines IL-4 and IL-10 secreted by Th2 cells were observed. TP could improve DN by regulating the Th1/Th2 cell balance. Macrophage infiltration as well as expression of inflammatory and pro-fibrogenic factors significantly increased in the kidneys of diabetic rats, which were suppressed by TP with the improvement in the medium-dose TP group (12 mg/kg/d) being the most significant.
CONCLUSION: TP can improve DN by regulating the Th1/Th2 cell balance and by reducing macrophage infiltration as well as the expression of relevant inflammatory factors in the kidney. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27328403     DOI: 10.1055/s-0042-106083

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  10 in total

1.  Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.

Authors:  Jian Gao; Zheng Liang; Fei Zhao; Xiaojing Liu; Ning Ma
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Activation of natural killer T cells contributes to triptolide-induced liver injury in mice.

Authors:  Xin-Zhi Wang; Ru-Feng Xue; Shen-Ye Zhang; Ya-Ting Zheng; Lu-Yong Zhang; Zhen-Zhou Jiang
Journal:  Acta Pharmacol Sin       Date:  2018-07-16       Impact factor: 6.150

3.  Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease.

Authors:  Mei Xue; Ying Cheng; Fei Han; Yunpeng Chang; Yang Yang; Xiaoyu Li; Li Chen; Yunhong Lu; Bei Sun; Liming Chen
Journal:  Int J Biol Sci       Date:  2018-09-07       Impact factor: 6.580

4.  In vivo protective effects of chlorogenic acid against triptolide-induced hepatotoxicity and its mechanism.

Authors:  Jun-Ming Wang; Rong-Xing Chen; Lu-Lu Zhang; Ning-Ning Ding; Chen Liu; Ying Cui; Yong-Xian Cheng
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

5.  A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.

Authors:  Yuyang Wang; Tongtong Liu; Fang Ma; Xiaoguang Lu; Huimin Mao; Weie Zhou; Liping Yang; Ping Li; Yongli Zhan
Journal:  J Diabetes Res       Date:  2020-11-20       Impact factor: 4.011

6.  Hyperoside Suppresses Renal Inflammation by Regulating Macrophage Polarization in Mice With Type 2 Diabetes Mellitus.

Authors:  Jialing Liu; Yanmei Zhang; Hongqin Sheng; Chunling Liang; Huazhen Liu; Jose Alberto Moran Guerrero; Zhaoyu Lu; Wei Mao; Zhenhua Dai; Xusheng Liu; Lei Zhang
Journal:  Front Immunol       Date:  2021-12-03       Impact factor: 7.561

Review 7.  Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease.

Authors:  Kaixuan Zhou; Xue Zi; Jiayu Song; Qiulu Zhao; Jia Liu; Huiwei Bao; Lijing Li
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

8.  Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway.

Authors:  Fei Han; Mei Xue; Yunpeng Chang; Xiaoyu Li; Yang Yang; Bei Sun; Liming Chen
Journal:  Int J Biol Sci       Date:  2017-09-21       Impact factor: 6.580

9.  Triptolide Restores Autophagy to Alleviate Diabetic Renal Fibrosis through the miR-141-3p/PTEN/Akt/mTOR Pathway.

Authors:  Xiao-Yu Li; Shan-Shan Wang; Zhe Han; Fei Han; Yun-Peng Chang; Yang Yang; Mei Xue; Bei Sun; Li-Ming Chen
Journal:  Mol Ther Nucleic Acids       Date:  2017-08-25

Review 10.  Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases-A Review.

Authors:  Kai Yuan; Xiaohong Li; Qingyi Lu; Qingqing Zhu; Haixu Jiang; Ting Wang; Guangrui Huang; Anlong Xu
Journal:  Front Pharmacol       Date:  2019-12-06       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.